6 results match your criteria: "Sunnybrook and Women's Health Science Center[Affiliation]"

The evolution of AO/ASIF views on fracture treatment, which has occured within last 50 years, is described in the present paper. In that time AO principles has been changed from mechanical approach to fracture care to methods considering first of all the biological aspects of injury. It has been manifested in invention of new implants of lower affect on bone tissue and emphasizing of soft tissue and atraumatic surgery technique importance.

View Article and Find Full Text PDF

Gene therapy in cancer.

J Exp Ther Oncol

April 2003

Sunnybrook and Women's Health Science Center, Department of Pathobiology and Laboratory Medicine, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario, Canada M4N 3M5.

Genetics have and will continue to have a strong and often controversial impact on our lives. Since the first human gene therapy in 1989, data from some 400 officially approved trials have been reported; only a handful appears promising. Of course, one must discern between gene replacements that correct inherited genetic disorders for life and the specific replacement of mutant genes that initiate or maintain the malignant phenotype with a correct gene copy.

View Article and Find Full Text PDF

Fibrous dysplasia of the temporal bone.

Otol Neurotol

May 2002

Department of Otolaryngology, Sunnybrook and Women's Health Science Center, 2075 Bayview Avenue, Toronto, Ontario, Canada M4N 3M5.

View Article and Find Full Text PDF

Raloxifene: another selective estrogen modulator.

In Vivo

September 2002

Department of Pathobiology and Laboratory Medicine, University of Toronto, Sunnybrook and Women's Health Science Center, Toronto, Ontario M4N 3M5, Canada.

The role of estrogens as one of the prime stimulators of tumor cell proliferation is well recognized; efforts to interfere with the initiation and promotion of breast and other cancers by endocrine manipulation have a long and successful past. The benzothiophene derivate Raloxifene is a relatively recent newcomer into a heterogeneous family of compounds loosely called antiestrogens, which implies their ability to act as antagonists to estrogen effects via competitive binding to various steroid receptors. This is a reductionist explanation, since their action is colorful and varied; they interact with lipid transduction cascades, covalently bind to DNA and to different proteins and regulate growth factors and the expression of various genes, such as erB2, mdr1 and p53; they complex with E-cadherin/catenin and are thus able to induce apoptosis, actively or indirectly.

View Article and Find Full Text PDF

Twenty-five patients with painful patella alta without symptomatic subluxation were identified in a prospective database. All patients had a distal tibial tubercle transfer and preoperative knee arthroscopy. The mean postoperative followup was 2.

View Article and Find Full Text PDF

Advances in nerve sparing for radical prostatectomy.

Urology

December 1999

Division of Urology, Sunnybrook and Women's Health Science Center, University of Toronto, Ontario, Canada.

View Article and Find Full Text PDF